ask="2.340"
ask_size="5500"
average_daily_volume="514468"
bid="2.140"
bid_size="6000"
book_value="4.005"
change="+0.115"
change_from_200_day_moving_average="-2.789"
change_from_50_day_moving_average="0.122"
change_from_52_week_high="-7.035"
change_From_52_week_low="0.315"
change_in_percent="+5.227%"
close="2.315"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.957"
ebitda="-30.59M"
eps_estimate_current_year="-2.090"
eps_estimate_next_quarter="-0.530"
eps_estimate_next_year="-1.880"
ex_dividend_date="N/A"
float_shares="8428000"
high="2.340"
high_52_weeks="9.350"
last_trade_date="2/1/2017"
last_trade_price="2.315"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.200"
low_52_weeks="2.000"
market_capitalization="35.98M"
moving_average_200_day="5.104"
moving_average_50_day="2.193"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.630"
open="2.200"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-54.646%"
percent_change_from_50_day_moving_average="+5.583%"
percent_change_from_52_week_high="-75.241%"
percent_change_from_52_week_low="+15.750%"
previous_close="2.200"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.549"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15543000"
short_ratio="0.440"
stock_exchange="NGM"
symbol="NVLS"
volume="652351"
weeks_range_52="2.000 - 9.350"
